0       0

Fetus and Newborn


THU1045 - Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid At All (Rx = .75 Hr.) ACPE #0263-000-18-946-L01-P (.75 Contact Hr.)


Sep 6, 2018 10:45am ‐ Sep 6, 2018 11:30am


Credits: None available.

Standard: $12.00

Description

Learning Objectives:

  • Evaluate common drug exposures in newborns, including the influence of pharmacokinetics on timing of withdrawal.
  • Recommend the optimal first-line therapy for neonatal abstinence syndrome, considering short-term and long-term outcomes.
  • Define the role of adjunctive pharmacotherapy in the treatment of neonatal abstinence syndrome.

Speaker(s):

Credits

  • 0.75 - Physician
  • 0.75 - RN / NP (All RNs/Nurses except CA RNs)
  • 0.90 - CA RN/CA BRN
  • 0.75 - Other

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content